Literature DB >> 2575811

Enzyme immunoassay for the detection of dengue IgG and IgM antibodies using infected mosquito cells as antigen.

L T Figueiredo1, M C Simões, S M Cavalcante.   

Abstract

The detection of immunoglobulin (Ig)G and IgM antibodies to dengue 1 virus was studied by a simple enzyme immunoassay, in which infected cultured cells infected with dengue virus were used as antigen (EIA-ICC). Detection of anti-dengue 1 IgG by EIA-ICC was correlated with haemagglutination assays. EIA-ICC anti-dengue 1 IgM detection was less sensitive than IgM capture enzyme-linked immunosorbent assay. IgG and IgM responses in dengue 1 infection were studied by EIA-ICC, using sera collected at different intervals after onset of illness: IgM and IgG appeared on the 4th day of disease; the highest IgM mean titres were detected on the 7th day and IgM was not detected in sera obtained after the 60th day; the highest mean titres of anti-dengue 1 IgG were seen in sera obtained between 22 and 30 d after onset of illness. EIA-ICCs for 6 flaviviruses and 1 alphavirus were conducted with sera from patients infected with dengue 1, and primary and secondary infections of other flaviviruses. The results showed that anti-dengue 1 IgG detection was sensitive, and the antibodies were cross-reactive among the flaviviruses. Anti-dengue 1 IgM detected in dengue 1 patients was mostly type specific. The pattern of secondary dengue infection, i.e. the presence of IgG and a low titre or absence of IgM antibodies, was observed in the sera of 6 patients obtained in the first week after onset of illness. EIA-ICC is useful for dengue diagnosis, surveillance and sero-epidemiological studies.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2575811     DOI: 10.1016/0035-9203(89)90403-3

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  4 in total

1.  Chikungunya and dengue fever among hospitalized febrile patients in northern Tanzania.

Authors:  Julian T Hertz; O Michael Munishi; Eng Eong Ooi; Shiqin Howe; Wen Yan Lim; Angelia Chow; Anne B Morrissey; John A Bartlett; Jecinta J Onyango; Venance P Maro; Grace D Kinabo; Wilbrod Saganda; Duane J Gubler; John A Crump
Journal:  Am J Trop Med Hyg       Date:  2012-01       Impact factor: 2.345

2.  Dengue antibodies in blood donors.

Authors:  Rejane Cristina Ribas-Silva; Andressa Ahmad Eid
Journal:  Rev Bras Hematol Hemoter       Date:  2012

3.  Mayaro virus infection in amazonia: a multimodel inference approach to risk factor assessment.

Authors:  Fernando Abad-Franch; Gustavo H Grimmer; Vanessa S de Paula; Luiz T M Figueiredo; Wornei S M Braga; Sérgio L B Luz
Journal:  PLoS Negl Trop Dis       Date:  2012-10-11

4.  Screening of Dengue virus antiviral activity of marine seaweeds by an in situ enzyme-linked immunosorbent assay.

Authors:  Andrea Cristine Koishi; Paula Rodrigues Zanello; Éverson Miguel Bianco; Juliano Bordignon; Claudia Nunes Duarte dos Santos
Journal:  PLoS One       Date:  2012-12-05       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.